The need to implement non-industry COVID-19 clinical trials in non-high-income countries.

Dal-Ré, Rafael; Carcas, Antonio J; Sreeharan, Nadarajah

Dal-Ré, Rafael; Carcas, Antonio J; Sreeharan, Nadarajah.

Dal-Ré R; Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
Carcas AJ; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Sreeharan N; Department of Medicine, University of Jaffna, Jaffna, Sri Lanka.

J Glob Health ; 10(1): 010351, 2020 Jun.

Article in English | MEDLINE | ID: covidwho-619031

Subject(s)

Coronavirus Infections/drug therapy; Developing Countries; Pneumonia, Viral/drug therapy; Randomized Controlled Trials as Topic; COVID-19; Coronavirus Infections/epidemiology; Drug Industry; Humans; Pandemics; Pneumonia, Viral/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Randomized Controlled Trials as Topic / Coronavirus Infections / Developing Countries Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Glob Health Year: 2020 Document Type: Article Affiliation country: Jogh.10.010351

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google